We evaluated clinical outcomes and prognostic factors associated with survival after balloon-occluded retrograde transvenous obliteration B-RTO of gastric varices in patients with portal hypertension. Of 50 patients with gastric varices who underwent B-RTO, 46 94.0% patients in whom B-RTO was technically successful were reviewed retrospectively. Gastric and esophageal varices after B-RTO were evaluated by contrast-enhanced computer tomography and endoscopy, respectively. Liver function parameters and Child-Pugh scores were estimated before and at 1 year after B-RTO. The cumulative survival rate was calculated, and univariate and multivariate analyses were used to assess the prognostic factors. No major complications occurred in any of the patients following B-RTO and no recurrence or bleeding of gastric varices was noted. Of the 42 patients who were followed up for the progression of esophageal varices, 13 31.0% had worsened varices and of these, 6 14.3% showed bleeding. Prothrombin activity had signi cantly improved at 1 year after B-RTO, although there were no changes in other liver function parameters. The overall cumulative survival rates at 1, 3, and 5 years after B-RTO were 91.6%, 70.9%, and 53.6%, respectively. Multivariate analysis identified the occurrence of advanced hepatocellular carcinoma HCC during the observation period as a prognostic factor for survival hazard ratio 4.1497, 95% CI 1.32314 13.0319, P 0.0148 . B-RTO of gastric varices is an effective treatment ensuring lower recurrence and bleeding rates ; however, these patients require careful observation for progression of esophageal varices. The management of HCC is crucial for achieving long-term survival after B-RTO.
Introduction
Portal hypertension causes gastroesophageal varices, which present a certain bleeding risk.
The prevalence of gastric fundal varices gastric varices in patients with portal hypertension is approximately 30%, which is lower than that of esophageal varices [1] [2] [3] . Although gastric varices also have lower reported bleeding rates 10-36% 4-6 than esophageal varices, the clinical outcomes of bleeding from gastric varices are comparatively worse and more serious than those associated with esophageal varices. Gastric variceal rupture is associated with a 25-55% mortality rate 3, 4, 7, 8 due to rapid and abundant blood ow in the major collateral veins.
Various endoscopic, surgical, and interventional techniques have been applied to treat gastric varices. In 1984, Olson et al 9 rst described a retrograde approach using a balloon catheter inserted into the draining vein of a gastrorenal shunt via the femoral vein, with ethanol as the sclerotic agent and metal coils used to induce gastric variceal thrombosis.
In 1991, Kanagawa et al 10 introduced a balloon-occluded retrograde transvenous obliteration B-RTO technique in Japan ; this procedure is now widely performed because of its satisfactory therapeutic ef cacy and low recurrence rates. Satisfactory prognosis has been reported after B-RTO, with cumulative survival rates at 1, 3, and 5 years of over 90%, 71-97%, and 54-82%, respectively [11] [12] [13] [14] [15] [16] .
The effectiveness of the treatment may be due to extreme changes in hepatic hemodynamics after B-RTO. According to portal phase splenic arteriography and computed tomography CT arterial portography via the splenic artery under conditions similar to those induced with the B-RTO procedure, the enhancement of the intrahepatic portal vein and liver parenchyma was depicted more clearly with occlusion of the major portosystemic shunts because of increased hepatopetal portal flow 17 . B-RTO with the occlusion of a major portosystemic shunt thus may increase the hepatic blood ow and possibly improve liver function. However, elevation of portal pressure may be expected after obliteration of a major portosystemic shunt, thus leading to ascites, aggravation of esophageal varices, and the appearance of ectopic varices, which are potential concerns for B-RTO. Consequently, B-RTO for patients with poor liver function reserve should be considered carefully ; here, endoscopy appears to be extremely important for identifying worsening esophageal varices.
The development of hepatocellular carcinoma HCC and the Child-Pugh classification were reported as prognostic factors associated with survival after B-RTO 11, 15, 18 . However, few studies have examined these prognostic factors in detail. This study evaluated clinical outcomes after B-RTO of gastric varices and investigated the prognostic factors associated with survival.
Methods
We retrospectively reviewed the medical records of all portal hypertension patients who underwent B-RTO of gastric varices at Showa University Hospital from January 2000 to October 2010.
Patients
We initially reviewed 50 patients with gastric varices who underwent B-RTO at our hospital. In 46 94.0% of these patients, B-RTO was technically successful, with complete thrombosis of the varices being achieved, as proved by contrast-enhanced CT. These patients were followed up and their cases were retrospectively reviewed. Table 1 summarizes the patient characteristics.
The varices were related to hepatitis B virus HBV infection, hepatitis C virus HCV infection, habitual alcohol consumption, and other conditions. According to the Child-Pugh classi cation system, 28 patients were categorized into class A, 17 into class B, and 1 was classi ed under class C. None had mild to severe ascites or symptomatic hepatic coma. The gastric varices in the fundus were subdivided into two types according to Sarin s classi cation 3, 7 : large gastric varices with esophageal varices GOV2 and isolated gastric varices IGV1 . GOV2 and IGV1 were found in 29 63.0% and 17 37.0% patients, respectively. Twenty of the total patients 43.5% had a history of bleeding from the gastric varices, although because the bleeding had already stopped during the endoscopic observation, B-RTO was scheduled without any endoscopic therapy. In the 26 remaining patients, B-RTO was performed as a prophylactic treatment. Twenty-nine 63.0% patients had esophageal varices before B-RTO ; of these, 28 had no previous episodes of bleeding, and thus endoscopic treatment for the esophageal varices was not performed before B-RTO.
The endoscopic ndings of the varices were evaluated according to the general rules proposed by the Japanese Research Society for Portal Hypertension 19 . Eight 17.4% patients had concomitant or past history of HCC without portal vein tumor thrombus, but the tumor was well controlled when B-RTO was performed.
B-RTO procedure
The presence of a portosystemic shunt, such as a gastrorenal shunt, was confirmed in all patients by multidetector-row CT or magnetic resonance imaging before B-RTO, which Yoshitomi, Osaka, Japan was intravenously administered before the injection of 5% EOI.
In general, the balloon catheter was positioned, 5% EOI was injected into the gastric variceal complex, and then the catheter was left in place overnight in all but 6 patients for whom the catheter was withdrawn after 30-60 min. On the next day, the balloon was de ated and the catheter was withdrawn after con rming thrombosis of the gastric varices by B-RTV.
Follow-up examination
To 
Results

Outcomes of B-RTO
Recurrence of gastric varices
Among the 46 patients, only 1 patient was lost to follow-up immediately after the rst evaluation. The 45 remaining patients were followed up for the recurrence of gastric varices over the median observation period of 10 months mean : 20.3 22.5 months ; range : 1-88 months . No recurrence or bleeding from the gastric varices was noted during the observation period in any of the patients.
Progression of esophageal varices
Of the 46 patients, 42 were followed up for the progression of esophageal varices Table   2 . These varices worsened in 13 31.0% patients ; moreover, 6 14.3% of them bled during the median observation period of 11.5 months mean : 19. One patient with F2 esophageal varices suffered a bleeding episode and required emergency treatment.
Changes in laboratory data and Child-Pugh scores
On average, the prothrombin activity significantly improved from 75.3 12.3% before B-RTO to 83.2 11.7% at 1 year after B-RTO n 26 ; Table 3 . However, the serum albumin level, total bilirubin level, and Child-Pugh scores did not change signi cantly after B-RTO.
Survival rate and clinical background
The median survival period was 13.5 months mean : 24.8 23.5 months ; range : 1-92 months . The overall cumulative survival rates at 1, 3, and 5 years after B-RTO were 91.6%, 70.9%, and 53.6%, respectively Fig. 1 . In all, 13 28.3% patients died of the Fig. 2 .
The median survival period was 18.0 months range : 1-92 months in the patients without advanced HCC n 36 and 12.5 months range : 3-66 months in those with advanced HCC n 10 . 
Discussion
Since its introduction by Kanagawa et al 10 , B-RTO has become widely accepted as a minimally invasive, highly effective treatment for gastric varices. In the present study, all the 46 patients who underwent technically successful B-RTO remained free of gastric variceal recurrence during the observation period ; their cumulative survival rates after B-RTO were 91.6% in the rst year, 70.9% in the third year, and 53.6% in the fth year. Further, the median survival periods were 5.5 months longer in the patients without advanced HCC than in those with advanced HCC. These results, which are similar to those reported previously [11] [12] [13] [14] [15] [16] , suggest that successful B-RTO has a stable long-term therapeutic effect.
Reported success rates of B-RTO of gastric varices are approximately 90% 11, 12, 14, 15 ; however, not all patients can be treated with this procedure. B-RTO may be associated with several technical dif culties leading to unfavorable results because of the complicated venous anatomy. The draining route from gastric varices is variable among patients, and unexpected collateral veins often develop. In general, B-RTO can be performed when there is a single gastrorenal shunt with minute collateral veins. stepwise injection 20 and/or a downgrading method 21 have been attempted in cases with one gastrorenal shunt and developing collateral veins. In cases of gastric varices without a gastrorenal shunt, standard B-RTO is Some reports have described the presence or absence of concomitant HCC and Child-Pugh classi cation as prognostic factors related to survival 11, 15, 18 . Our strategy of treatment for gastric varices excluded patients with Child-Pugh class C and concomitant advanced HCC, because the bene t of B-RTO remains unclear in Child-Pugh class C patients 30 . We considered that the occurrence of advanced HCC is signi cantly associated with survival after B-RTO because of poor prognoses in the observation period. The development of HCC in chronic liver disease was the most common cause of death in our patients. Satisfactory survival would depend upon careful management for preventing the advancement of HCC.
In conclusion, B-RTO of gastric varices is an effective treatment ensuring low recurrence and bleeding rates ; however, these patients require careful observation for the progression of esophageal varices. The present study also identi ed the occurrence of advanced HCC as a prognostic factor for survival in patients with gastric varices after B-RTO. We believe that B-RTO will become the standard treatment for gastric varices with gastrorenal shunts, although treating worsened esophageal varices may be necessary after B-RTO.
